BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 34339393)

  • 1. Association between
    Zhou C; Gao S; Yuan X; Shu Z; Li S; Sun X; Xiao J; Liu H
    Aging (Albany NY); 2021 Aug; 13(15):19397-19414. PubMed ID: 34339393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of CTLA-4 A49G polymorphism on rheumatoid arthritis risk: a meta-analysis.
    Li G; Shi F; Liu J; Li Y
    Diagn Pathol; 2014 Aug; 9():157. PubMed ID: 25128482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between the CTLA-4 +49 A/G polymorphism and susceptibility to rheumatoid arthritis: a meta-analysis.
    Lee YH; Bae SC; Choi SJ; Ji JD; Song GG
    Mol Biol Rep; 2012 May; 39(5):5599-605. PubMed ID: 22179750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTLA-4 +49 G/A Polymorphism Confers Autoimmune Disease Risk: An Updated Meta-Analysis.
    Wang K; Zhu Q; Lu Y; Lu H; Zhang F; Wang X; Fan Y
    Genet Test Mol Biomarkers; 2017 Apr; 21(4):222-227. PubMed ID: 28384040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of associations between XRCC1 gene polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis.
    Zhang MY; Yang XK; Lv TT; Wu J; Xu SZ; Wang JB; Pan HF; Ye DQ
    Int J Rheum Dis; 2018 Jan; 21(1):179-185. PubMed ID: 28198159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of CTLA-4 (+49 A/G) polymorphism with susceptibility to autoimmune diseases: A meta-analysis with trial sequential analysis.
    Yu L; Shao M; Zhou T; Xie H; Wang F; Kong J; Xu S; Shuai Z; Pan F
    Int Immunopharmacol; 2021 Jul; 96():107617. PubMed ID: 33866246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in the CTLA-4 gene and rheumatoid arthritis susceptibility: a meta-analysis.
    Li X; Zhang C; Zhang J; Zhang Y; Wu Z; Yang L; Xiang Z; Qi Z; Zhang X; Xiao X
    J Clin Immunol; 2012 Jun; 32(3):530-9. PubMed ID: 22354566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between cytotoxic T-lymphocyte-associated antigen 4 gene polymorphisms and diabetes mellitus: a meta-analysis of 76 case-control studies.
    Chen M; Li S
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988065
    [No Abstract]   [Full Text] [Related]  

  • 9. Meta-analysis: the relationship between CTLA-4 +49 A/G polymorphism and primary biliary cirrhosis and type I autoimmune hepatitis.
    Eskandari-Nasab E; Tahmasebi A; Hashemi M
    Immunol Invest; 2015; 44(4):331-48. PubMed ID: 25942345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of the cytotoxic T-lymphocyte antigen 4 gene +6230G/A polymorphism and cancer risk.
    Zhao HY; Duan HX; Gu Y
    Clin Transl Oncol; 2014 Oct; 16(10):879-85. PubMed ID: 24493286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis.
    Zhang C; Hou WH; Ding XX; Wang X; Zhao H; Han XW; Wang WJ
    Asian Pac J Cancer Prev; 2016; 17(8):3785-91. PubMed ID: 27644617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the CTLA-4 +49A/G polymorphism with rheumatoid arthritis in Chinese Han population.
    Tang MJ; Zhou ZB
    Mol Biol Rep; 2013 Mar; 40(3):2627-31. PubMed ID: 23264071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The -319C/+49G/CT60G haplotype of CTLA-4 gene confers susceptibility to rheumatoid arthritis in Mexican population.
    Torres-Carrillo N; Ontiveros-Mercado H; Torres-Carrillo NM; Parra-Rojas I; Rangel-Villalobos H; Ramírez-Dueñas MG; Gutiérrez-Ureña SR; Valle Y; Muñoz-Valle JF
    Cell Biochem Biophys; 2013; 67(3):1217-28. PubMed ID: 23703660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association among cytotoxic T-lymphocyte antigen 4 gene, rs231775 polymorphism, and recurrent pregnancy loss risk.
    Song Y; Chen Y; Xu Q
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30578376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Association of CTLA-4 rs231775 and rs3087243 Polymorphisms with Latent Autoimmune Diabetes in Adults: A Meta-Analysis.
    Pang H; Luo S; Huang G; Li X; Xie Z; Zhou Z
    Biochem Genet; 2022 Aug; 60(4):1222-1235. PubMed ID: 34822071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between the CTLA-4, CD226, FAS polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis.
    Lee YH; Bae SC; Song GG
    Hum Immunol; 2015 Mar; 76(2-3):83-9. PubMed ID: 25645050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTLA-4 rs5742909 polymorphism and cervical cancer risk: A meta-analysis.
    Hu S; Pu D; Xia X; Guo B; Zhang C
    Medicine (Baltimore); 2020 Mar; 99(11):e19433. PubMed ID: 32176070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant association between cytotoxic T lymphocyte antigen 4 +49G>A polymorphism and risk of malignant bone tumors.
    Yu F; Miao J
    Tumour Biol; 2013 Dec; 34(6):3371-5. PubMed ID: 23900675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of the association between the single-nucleotide polymorphism of co-stimulatory system and rheumatoid arthritis.
    Chen DP; Wen YH; Lin WT; Hsu FP; Yu KH
    Front Immunol; 2023; 14():1123832. PubMed ID: 37457686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between CTLA-4 exon-1 +49A/G polymorphism and systemic lupus erythematosus: an updated analysis.
    Chang WW; Zhang L; Yao YS; Su H
    Mol Biol Rep; 2012 Sep; 39(9):9159-65. PubMed ID: 22718509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.